Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

Against the background of an increasingly aging global population, the incidence of thrombotic and hemostatic diseases, including cardiovascular diseases, remains high.

Shenzhen New Industries Biomedical Engineering Co., LTD., which was officially listed on the Gem of Shenzhen Stock Exchange on May 12, 2020,realized 97,0101,600 yuan of revenue, an increase of 31.06% over the same period last year.

Mindray is expected to achieve the operating income of 14.855 billion yuan to 16.093 billion yuan in the first three quarters of 2020, a year-on-year growth of 20% to 30%; Kehua announced that the company expects the net profit of the first

On Sep. 25th, Upper Biotech applied for IPO was accepted by Shanghai Stock Exchange. At present, it has 7 listed enterprise on STAR Market, 2 registered upcoming companies and 5 waitings.

October 9, with the endorsement of Premier Li Keqiang, the State Council issued the Opinions on Further Improving the Quality of Listed Companies (hereinafter referred to as the Opinions).

From August to September 2020, the COVID-19 testing products of 5 companies around the world are included in the World Health Organization (WHO) Emergency Use Listing (the full English name is "Emergency Use Listing", "EUL" for short), of wh

From July to September, eight Chinese in vitro diagnostic companies have successively obtained Emergency Use Authorization(EUA) issued by US Food and Drug Administration (FDA) .

NGS cancer companion diagnostics is an emerging industry in China, and its industry concentration has gradually increased over the past 6 years around development.

The Supreme Law and the National Medical Insurance Bureau issued a document: From now on, medical commercial bribery cases will be notified to the Medical Insurance Bureau

Recently, Gofar issued a report (draft) on the acquisition of KOALSON, proposing to purchase the 99.9779% of KOALSON's shares held by eight people with the transaction price of about 356 million yuan by issuing shares and paying cash.

In Sep. 16th, Zhejiang Gongdong Medical Technology Co., Ltd. successfully listed on SSE (Shanghai Stock Exchange).